Speakers

Dr Bettina Rietz-Wolf

Dr Bettina Rietz-Wolf

Regierungspräsidium Tübingen

Luigi Scaffidi

Luigi Scaffidi

Boehringer Ingelheim Pharma

Dr Florian Witte

Dr Florian Witte

Boehringer Ingelheim

A discount of €500 applies when booking this course together with the course "GMP for Beginners in Sterile Manufacturing".

Exercises / Case Studies on: Design of a Media Fill | Risk-Based Determination of Interventions | Managing Deviations


Target Group

This Education course is directed at staff from
  •  Production
  •  Quality Assurance
  •  Microbiological Quality Control
who are responsible for the planning and evaluation of Aseptic Process Simulation (Media fill) programmes.

It is also valuable for decision makers who have to deal with Process Simulation data within the framework of production release and Aseptic Process Validation.

Objectives

During this course you will learn in lectures and workshops
  •  The new requirements of the revised EU Annex 1
  •  How to plan a media fill in compliance with European and US GMP requirements,
  •  How to interpret the results of a media fill,
  •  How to investigate deviations and define follow-up measures and
  •  How QA should be involved
Background
In the aseptic processing of medicinal products, product quality usually cannot be ensured solely by laboratory testing of the final product. Process validation by means of media fills is therefore the only way to provide evidence of product safety. For this reason, media fills are rightly a major focus of regulatory requirements and official inspections.

A number of revised and harmonised international regulations—particularly the FDA Guidance for Industry “Sterile Drug Products Produced by Aseptic Processing”, the EU GMP Guide Annex 1, ISO 13408, and the PIC/S Guide “Recommendation on the Validation of Aseptic Processes”—define highly detailed requirements. The implementation of these requirements is critically assessed during official inspections.

In general, required media fills should be capable of simulating both routine operating conditions and worst-case scenarios.
In practice, however, questions of feasibility often arise. How should these requirements be interpreted, and how can they be implemented, even for special production processes or dosage forms?


Programme

Current Regulatory Requirements and Expectations of an Inspector
  • EU-GMP Guide Annex 1
  • Regulatory changes through the new EU GMP Guide Annex 1
  • Contamination control
  • Inspection practice, questions
    • Design
    • Interventions
    • Visual inspection
    • Target, assessment
  • Media Fill observations
Requirements for Cleanroom Staff Qualification
  • Staff qualification
  • Staff disqualification
  • Training
  • Gowning qualification
  • Qualification with APS (success control)
  • Personnel monitoring
Design of Media Fill incl. Exercise
  • Overview PDA TR22
  • Parameter, which have to be consider in MF design
  • Different MF design alternatives
  • Consideration of long filling times
  • Consideration of holding times
  • The role of the MF in aseptic personnel qualification
Risk Management During Media Fill (Bracketing / Definition of Simulations / Interventions)
  • Approaches and parameters for bracketing concepts
  • Classification and grouping of interventions
  • Examples of simulations
  • Influence of the barrier system
  • Examples of risk management tools
QA-Oversight
  • Regulatory requirements
  • Different approaches to QA Oversight
  • Oversight during Media Fill execution
  • Link between Media Fill interventions and smoke studies
Exercise: Risk-based Determination of Interventions
 
Microbiological Investigations and Environmental Monitoring as Part of the Media Fill
  • EM and personnel monitoring during Media Fill
  • Responsibility for execution
  • Fertility testing of the growth medium
Incubation, Assessment and Evaluation
  • Important conditions for visual inspection
  • Personnel qualification
  • Evaluation methods for the Media Fill


Further Information

Technical Requirements
We use Webex for our live online training courses and webinars. At https://www.gmp-compliance.org/training/online-training-technical-information you will find all the information you need to participate in our events and you can check if your system meets the necessary requirements to participate. If the installation of browser extensions is not possible due to your rights in the IT system, please contact your IT department. Webex is a standard nowadays and the necessary installation is fast and easy.

Fees (per delegate plus VAT)
ECA Members € 1,890
APIC Members € 1,990
Non-ECA Members € 2,090
EU GMP Inspectorates € 1,045
The conference fee is payable in advance after receipt of invoice.

Presentations/Certificate
The presentations will be made available to you prior to the Live Online Training as PDF files. After the event, you will automatically receive your certificate of participation.

Conference language
The official conference language will be English.

Contacts
Questions regarding content:
Mr Clemens Mundo (Operations Director), +49 6221 84 44-42, mundo@concept-heidelberg.de
Questions regarding organisation:
Ms Nicole Bach (Organisation Manager), +49 6221 84 44-22, nicole.bach@concept-heidelberg.de.


Date & Time

Thu, 19 Nov 2026, 9:00 – 17:30 h
Fri, 20 Nov 2026, 9:00 – 15:30 h
All times mentioned are CET

Costs

ECA-Member*: € 1890,-
Non ECA Member*: € 2090,-
EU/GMP Inspectorates*: € 1045,-
APIC Member Discount*: € 1990,-

(All prices excl. VAT). Important notes on sales tax.

* also payable by credit card
American Express Visa Mastercard

icon
Recording/ Additional dates on-site
not available
Recording/ Additional dates on-site
not available
stop

This course is part of the GMP Certification Programme "ECA Certified Sterile Production Manager"

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0
E-Mail: info@gmp-compliance.org

Woman with headset

Go back

Testimonials about our courses and conferences

"Great material and speakers" and "Great speakers a lot of experience and sharing"

Felipe Gonzalez, Mucos Emulsionsgesellschaft mbH
Live Online Training - Granulation & Tableting, September 2024

“I found the course eye opening and very well organized.”

Jozsef Maklary, Veolia Industries Austria GmbH
The GMP-Compliance Manager, October 2025

"I am so grateful for having attended this course. Great job from all, and very profitable. Thanks!”

Alba Aranda Cuesta, Kern Pharma
KPIs and Quality Metrics, Berlin, Germany, April 2025

"The lectures were very informative, interesting and entertaining."

Albert Godoy Hernández, Company synaffix
Live Online Training - GMP Auditor Practice, October 2024

"Really useful training which I will use in my daily work."

Regina Mommaerts, Galapagos NV
Live Online Training - GMP Auditor Practice, October 2024

"Wonderful format of the sessions: Good range of participations and experience in the team. Would love to attend another one soon."

Roopasi Mathi, Wacker Biotech B.V.
Live Online Training - GMP Auditor Practice, October 2024

"Very good balance between general and detailed information"

Dr Ralf Albrecht, Tillotts Pharma AG
Live Online Training - Granulation & Tableting
September 2024

"Nice presentations: easy understanding, quite visual"

Susana Manrique, Boehringer Ingelheim España, S.A,
Live Online Training - Granulation & Tableting, September 2024

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023

 

“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024

 

“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024

 

 

“Both, organizers and lecturers were very friendly, open for discussions and extremely constructive. The course was a valuable experience for me.”

Maria Dimitrova, NKN Law Firm
Pharmaceutical Contracts: GMP and Legal Compliance, March 2025